Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2012
11/01/2012US20120278951 Modified oil encapsulating proteins and uses thereof
11/01/2012US20120278949 Shine clade of transcription factors and their use
11/01/2012US20120278946 Isolation of proteins involved in posttranscriptional gene silencing and methods of use
11/01/2012US20120278936 Plants and seeds of corn variety cv789457
11/01/2012US20120278935 Plants and seeds of corn variety cv038052
11/01/2012US20120278933 Plants and seeds of corn variety cv927887
11/01/2012US20120278914 Methods and compositions for regulating production of proanthocyanidins
11/01/2012US20120278909 Compositions and methods for determining genetic polymorphisms in the tmem216 gene
11/01/2012US20120277414 PROTEIN PHOTOELECTRIC TRANSDUCER AND TIN-SUBSTITUTED CYTOCHROME c
11/01/2012US20120277413 Dendritic Cell Marker BDCA-2 Protein Sequence
11/01/2012US20120277411 Single chain antibodies for photosynthetic microorganisms and methods of use
11/01/2012US20120277409 Metal-polysaccharide conjugates: compositions, synthesis and methods for cancer therapy
11/01/2012US20120277408 High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
11/01/2012US20120277282 Polynucleotides for use in medicine
11/01/2012US20120277166 Conotoxin peptides useful as inhibitors of neuronal amine transporters
11/01/2012US20120277162 Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/01/2012US20120277160 Composition for improving brain function and method for improving brain function
11/01/2012US20120277158 Compositions and methods for the transport of therapeutic agents
11/01/2012US20120277148 Insulin analogues with chlorinated amino acids
11/01/2012US20120277144 Novel compounds for modulating neovascularisation and methods of treatment using these compounds
11/01/2012US20120277143 IL4/IL13 Binding Repeat Proteins and Uses
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120277122 GFABS: GFP-Based Biosensors Possessing the Binding Properties of Antibodies
11/01/2012US20120276655 Detection of antibodies
11/01/2012US20120276590 Recombinant silkworm and silkworm protein comprising heterologous protein produced by the recombinant silkworm
11/01/2012US20120276559 Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
11/01/2012US20120276554 Isolation and use of ryanodine receptors
11/01/2012US20120276548 Multimer glycosylated nucleic acid binding protein conjugates and uses thereof
11/01/2012US20120276185 Soluble coating comprising polyelectrolyte with hydrophobic counterions
11/01/2012US20120276161 Bioresorbable and biocompatible compounds for surgical use
11/01/2012US20120276159 Tolerogenic synthetic nanocarriers
11/01/2012US20120276148 Adenoviral vector vaccine
11/01/2012US20120276145 Extracellular matrix proteins from haemophilus influenzae biofilms: targets for therapeutic or diagnostic use
11/01/2012US20120276142 Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
11/01/2012US20120276141 Env polypeptide complexes and methods of use
11/01/2012US20120276137 Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
11/01/2012US20120276136 Chemically programmable immunity
11/01/2012US20120276135 Methods for improving the design, bioavailability, and efficacy of random sequence polymer compositions via serum protein-based detection of random sequence polymer compositions
11/01/2012US20120276129 Neisserial antigenic peptides
11/01/2012US20120276128 HIV Envelope-CD4 Complexes and Hybrids
11/01/2012US20120276125 Novel immunoconjugates
11/01/2012US20120276116 Prevention and Treatment of Amyloidogenic Disease
11/01/2012US20120276107 Methods and Compositions for Mycoplasma Pneumoniae Exotoxins
11/01/2012US20120276101 Viral chemokine-antigen fusion proteins
11/01/2012US20120276082 Treatment of cancer
11/01/2012US20120276073 Treatment of nerve injuries
11/01/2012US20120276072 Constructs for expressing lysosomal polypeptides
11/01/2012US20120276052 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
11/01/2012US20120273993 Method of generating collagen fibers
11/01/2012CA2834624A1 Il4/il13 binding repeat proteins and uses
11/01/2012CA2834516A1 Mfg-e8 and uses thereof
11/01/2012CA2834508A1 Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
11/01/2012CA2834288A1 Truncated hiv envelope proteins (env), methods and compositions related thereto
11/01/2012CA2834255A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012CA2833876A1 Down-regulation of a homeodomain-leucine zipper i-class homeobox gene for improved plant performance
11/01/2012CA2831008A1 Novel immunoconjugates
11/01/2012CA2828634A1 Aptamer -modified polymeric materials for the binding of therapeutic factors in a wound environment
10/2012
10/31/2012EP2518496A2 BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
10/31/2012EP2518151A1 Caustic stable chromatography ligands
10/31/2012EP2518149A1 HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
10/31/2012EP2518148A1 GENE Dro1 CONTROLLING DEEP-ROOTED CHARACTERISTICS OF PLANT AND UTILIZATION OF SAME
10/31/2012EP2518142A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
10/31/2012EP2518086A1 Radiolabeled compound directable in vivo to target tissue and use thereof
10/31/2012EP2518082A2 Means for the inhibition of anti-beta1-adrenergic receptor antibodies
10/31/2012EP2518081A1 Method of producing and purifying polymeric proteins in transgenic plants
10/31/2012EP2517731A1 Method of activating a target gene in a cell
10/31/2012EP2517725A1 Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
10/31/2012EP2517720A1 Stabilized therapeutic small helical antiviral peptides
10/31/2012EP2517002A1 Insulin receptor substrate 1 (irs1) protein srm/mrm assay
10/31/2012EP2516646A2 Method of treatment and screening method
10/31/2012EP2516636A1 Methods for producing heterologous polypeptides in thiol-disulfide oxidoreductase-deficient bacterial mutant cells
10/31/2012EP2516464A1 Recombinant factor h and variants and conjugates thereof
10/31/2012EP2516459A1 Bivalent molecules for hiv entry inhibition
10/31/2012EP2516458A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy
10/31/2012EP2516457A1 Humanized fc gamma r mice
10/31/2012EP2516456A1 Bmp-7 variants with reduced immunogenicity
10/31/2012EP2516455A1 Modified porcine somatotropin polypeptides and their uses
10/31/2012EP2516454A1 Modified bovine somatotropin polypeptides and their uses
10/31/2012EP2516453A1 Antimicrobial peptides
10/31/2012EP2516452A1 Mutant nisin ser 29 derivatives and the use thereof
10/31/2012EP2516451A2 Thermostable xylanase for the selective hydrolysis of pentose-containing polysaccharides
10/31/2012EP2515934A2 Vaccine compositions
10/31/2012EP2515928A1 Oxyntomodulin peptide analogue
10/31/2012EP2515927A1 Oxyntomodulin peptide analogue
10/31/2012EP2515926A1 Compositions and methods for the treatment of angiogenesis-related eye diseases
10/31/2012EP2515797A1 Collagen fiber constructs for replacing cruciate ligaments
10/31/2012CN1612750B TACI-immunoglobulin fusion proteins
10/31/2012CN102762732A Bacterial host strain comprising a mutant SPR gene and having reduced TSP activity
10/31/2012CN102762723A Methods for producing heterologous polypeptides in thiol-disulfide oxidoreductase-deficient bacterial mutant cells
10/31/2012CN102762591A Fibronectin based scaffold domain proteins that bind il-23
10/31/2012CN102762590A Humanized fc[gamma]r mice
10/31/2012CN102762589A Insulin analogues with chlorinated amino acids
10/31/2012CN102762588A Anti-trypanosome therapeutic and diagnostic applications
10/31/2012CN102762224A Vaccine compositions
10/31/2012CN102762096A Modified cry1ca insecticidal cry proteins
10/31/2012CN102757992A Method for enriching glycopeptide with combination of polyethylene glycol coupling and ultrafiltration centrifugal separation
10/31/2012CN102757977A Expression and preparation method of granulysin
10/31/2012CN102757974A Novel preparation method for recombinant human epidermal growth factor
10/31/2012CN102757971A Mycobacterium tuberculosis recombinant protein and preparation method thereof
10/31/2012CN102757970A Eucalyptus PGEF12 gene as well as plant expression vector thereof, host cell thereof and application thereof
1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 2916